Cargando…
Can Biological Drugs Diminish the Risk of Sarcopenia in Psoriatic Patients? A Systematic Review
Sarcopenia and psoriasis are different inflammatory diseases that share common comorbidities (e.g., cardiovascular diseases, metabolic syndrome, obesity, autoimmune diseases, depression). Psoriasis is a dermatosis involving the skin, joints, and nails. Its estimated prevalence is 2–4%, and the possi...
Autores principales: | Piętowska, Zuzanna, Nowicka, Danuta, Szepietowski, Jacek |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8952562/ https://www.ncbi.nlm.nih.gov/pubmed/35330186 http://dx.doi.org/10.3390/life12030435 |
Ejemplares similares
-
Understanding Melasma-How Can Pharmacology and Cosmetology Procedures and Prevention Help to Achieve Optimal Treatment Results? A Narrative Review
por: Piętowska, Zuzanna, et al.
Publicado: (2022) -
Human Stem Cell Use in Androgenetic Alopecia: A Systematic Review
por: Krefft-Trzciniecka, Katarzyna, et al.
Publicado: (2023) -
Chitinase-3-like protein 1 (YKL-40) is a biomarker of severity of joint involvement in psoriatic arthritis
por: Salomon, Joanna, et al.
Publicado: (2018) -
Inflammaging and Immunosenescence as Part of Skin Aging—A Narrative Review
por: Pająk, Justyna, et al.
Publicado: (2023) -
Prevention of Ageing—The Role of Micro-Needling in Neck and Cleavage Rejuvenation: A Narrative Review
por: Pająk, Justyna, et al.
Publicado: (2022)